Top

Osteoporosis International

Published in:

01-11-2007 | Original Article

Complementary and alternative medicine use by osteoporosis clinic patients

Authors: C. A. K. Y. Chong, N. Diaz-Granados, G. A. Hawker, S. Jamal, R. G. Josse, A. M. Cheung

Published in: Osteoporosis International | Issue 11/2007

Abstract

Summary

We describe complementary and alternative medicine use (CAM) in 360 patients attending osteoporosis clinics. Of these patients, 57% were CAM users. Predictors of CAM use included lower mental quality of life, younger age and higher education. Less than half of CAM use was disclosed to physicians, despite potential adverse interactions.

Introduction

The prevalence of complementary and alternative medicine (CAM) use in osteoporosis clinics is not known. The objective of this study was to describe the pattern of CAM use in this population.

Methods

We performed a cross-sectional study of 360 patients attending academic osteoporosis clinics in Toronto, Canada in 2001. Subjects completed a self-administered questionnaire on CAM use. Health-related quality of life (HQL) was measured with the Short-Form 36v2. Comparative statistics and logistic regression were performed to identify sociodemographic, HQL and clinical correlates of CAM use.

Results

More than 80% of participants were women, Caucasian and had at least a high school education. Of subjects, 57% used CAM in the previous year. Only 44% of CAM use was disclosed to a medical doctor. CAM users and non-users did not differ in clinical characteristics such as bone mineral density, level of comorbidity and fracture history. In univariate analysis, CAM users were less satisfied with conventional medicine. However, when we explored patient satisfaction, comorbidities and sociodemographic as predictors for CAM use, the multivariable analyses showed that lower mental HQL, younger age, and post-secondary education were the only significant predictors. We identified 35 cases in which the utilization of CAM supplements could possibly exacerbate existing medical conditions.

Conclusion

Patients attending osteoporosis clinics frequently use CAM. Conceptually, the predictors of use identified in this study may fit into a socio-behavioral model that helps explain why people turn to CAM. Physicians may need to elicit a history of CAM use more vigilantly so as to better screen for possible adverse clinical interactions.

Millar WJ (1997) Use of alternative health care practitioners by Canadians. Can J Public Health 88:154–158PubMed

Eisenberg DM, Davis RB, Ettner SL et al (1998) Trends in alternative medicine use in the United States, 1990–1997: results of a follow-up national survey. JAMA 280:1569–1575PubMedCrossRef

Tindle HA, Davis RB, Phillips RS et al (2005) Trends in use of complementary and alternative medicine by US adults: 1997–2002. Altern Ther Health Med 11:42–49PubMed

Verhoef MJ, Hagen N, Pelletier G et al (1999) Alternative therapy use in neurologic diseases: use in brain tumor patients. Neurology 52:617–622PubMed

Pioro-Boisset M, Esdaile JM, Fitzcharles MA (1996) Alternative medicine use in fibromyalgia syndrome. Arthritis Care Res 9:13–17PubMedCrossRef

Ganguli SC, Cawdron R, Irvine EJ (2004) Alternative medicine use by Canadian ambulatory gastroenterology patients: secular trend or epidemic? Am J Gastroenterol 99:319–326PubMedCrossRef

Eisenberg DM, Kessler RC, Foster C et al (1993) Unconventional medicine in the United States. Prevalence, costs, and patterns of use. N Engl J Med 328:246–252PubMedCrossRef

MacLennan AH, Wilson DH, Taylor AW (1996) Prevalence and cost of alternative medicine in Australia. Lancet 347:569–573PubMedCrossRef

Sirois FM, Gick ML (2002) An investigation of the health beliefs and motivations of complementary medicine clients. Soc Sci Med 55:1025–1103PubMedCrossRef

10.

Astin JA (1998) Why patients use alternative medicine: results of a national study. JAMA 279:1548–1553PubMedCrossRef

11.

Seidl MM, Stewart DE (1998) Alternative treatments for menopausal symptoms. Systematic review of scientific and lay literature. Can Fam Physician 44:1299–1308PubMed

12.

Kam IW, Dennehy CE, Tsourounis C (2002) Dietary supplement use among menopausal women attending a San Francisco health conference. Menopause 9:72–78PubMedCrossRef

13.

Daniel W (1999) Biostatistics: A Foundation for Analysis in the Health Sciences, 7th edn. John Wiley Sons, John Wiley Sons: New York

14.

(2001) Population Counts, Land Area, Population Density and Population Rank, for Canada, Provinces and Territories, and Census Subdivisions (Municiplaities), 2001 Census. Statistics Canada

15.

National Center for Complementary and Alternative Medicine. (2007) CAM Basics. Available at: http://nccam.nih.gov/health/whatiscam/. Accessed February 15, 2007

16.

Burstein HJ, Gelber S, Guadagnoli E et al (1999) Use of alternative medicine by women with early-stage breast cancer. N Engl J Med 340:1733–1739PubMedCrossRef

17.

Moore AD, Petri MA, Manzi S et al (2000) The use of alternative medical therapies in patients with systemic lupus erythematosus. Trination Study Group. Arthritis Rheum 43:1410–1418PubMedCrossRef

18.

Ware JE Jr, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30:473–483PubMedCrossRef

19.

Hopman WM, Towheed T, Anastassiades T et al (2000) Canadian normative data for the SF-36 health survey. Canadian Multicentre Osteoporosis Study Research Group. CMAJ 163:265–271PubMed

20.

Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383PubMedCrossRef

21.

Chaudhry S, Jin L, Meltzer D (2005) Use of a self-report-generated Charlson Comorbidity Index for predicting mortality. Med Care 43:607–615PubMedCrossRef

22.

Kanis JA, Melton LJ 3rd, Christiansen C, Johnston CC, Khaltaev N (1994) The diagnosis of osteoporosis. J Bone Miner Res 9:1137–1141PubMedCrossRef

23.

Tenenhouse A, Joseph L, Kreiger N et al (2000) Estimation of the prevalence of low bone density in Canadian women and men using a population-specific DXA reference standard: the Canadian Multicentre Osteoporosis Study (CaMos). Osteoporos Int 11:897–904PubMedCrossRef

24.

(2001) Median total income, by family type, by census metropolitan area. Statistics Canada

25.

Yue QY, Jansson K (2001) Herbal drug curbicin and anticoagulant effect with and without warfarin: possibly related to the vitamin E component. J Am Geriatr Soc 49:838PubMedCrossRef

26.

Corrigan JJ Jr, Ulfers LL (1981) Effect of vitamin E on prothrombin levels in warfarin-induced vitamin K deficiency. Am J Clin Nutr 34: 1701–1705PubMed

27.

Corrigan JJ Jr, Marcus FI (1974) Coagulopathy associated with vitamin E ingestion. JAMA 230:1300–1301PubMedCrossRef

28.

Monauni T, Zenti MG, Cretti A et al (2000) Effects of glucosamine infusion on insulin secretion and insulin action in humans. Diabetes 49:926–935PubMedCrossRef

29.

Adams ME (1999) Hype about glucosamine. Lancet 354:353–354PubMedCrossRef

30.

Schelling JR (2000) Fatal hypermagnesemia. Clin Nephrol 53:61–65PubMed

31.

This P, De La Rochefordiere A, Clough K et al (2001) Phytoestrogens after breast cancer. Endocr Relat Cancer 8:129–134PubMedCrossRef

32.

Glazier MG, Bowman MA (2001) A review of the evidence for the use of phytoestrogens as a replacement for traditional estrogen replacement therapy. Arch Intern Med 161:1161–1172PubMedCrossRef

33.

Miller LG (1998) Herbal medicinals: selected clinical considerations focusing on known or potential drug-herb interactions. Arch Intern Med 158:2200–2211PubMedCrossRef

34.

Ernst E, Harkness E (2001) Spinal manipulation: a systematic review of sham-controlled, double-blind, randomized clinical trials. J Pain Symptom Manage 22:879–889PubMedCrossRef

35.

Monostory K, Vereczkey L, Levai F, Szatmari I (1998) Ipriflavone as an inhibitor of human cytochrome P450 enzymes. Br J Pharmacol 123:605–610PubMedCrossRef

36.

Alexandersen P, Toussaint A, Christiansen C, Devogelaer JP, Roux C, Fechtenbaum J, Gennari C, Reginster JY (2001) Ipriflavone in the treatment of postmenopausal osteoporosis: a randomized controlled trial. JAMA 285:1482–1488PubMedCrossRef

37.

Hsiao AF, Wong MD, Kanouse DE et al (2003) Complementary and alternative medicine use and substitution for conventional therapy by HIV-infected patients. J Acquir Immune Defic Syndr 33:157–165PubMedCrossRef

38.

Gagnon EM, Recklitis CJ (2003) Parents’ decision-making preferences in pediatric oncology: the relationship to health care involvement and complementary therapy use. Psychooncology 12:442–452PubMedCrossRef

39.

Arcury TA, Bell RA, Snively BM et al (2006) Complementary and alternative medicine use as health self-management: rural older adults with diabetes. J Gerontol B Psychol Sci Soc Sci 61:S62–S70PubMed

40.

Andersen R, Newman JF (1973) Societal and individual determinants of medical care utilization in the United States. Milbank Mem Fund Q Health Soc. 51:95–124PubMedCrossRef

41.

Schwartz CE, Laitin E, Brotman S et al (1999) Utilization of unconventional treatments by persons with MS: is it alternative or complementary? Neurology 52:626–629PubMed

Title: Complementary and alternative medicine use by osteoporosis clinic patients
Authors: C. A. K. Y. Chong
N. Diaz-Granados
G. A. Hawker
S. Jamal
R. G. Josse
A. M. Cheung
Publication date: 01-11-2007
Publisher: Springer-Verlag
Published in: Osteoporosis International / Issue 11/2007
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI: https://doi.org/10.1007/s00198-007-0417-x

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Complementary and alternative medicine use by osteoporosis clinic patients

Abstract

Summary

Introduction

Methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Summary

Introduction

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 11/2007

Hypovitaminosis D and secondary hyperparathyroidism in the elderly: risk factors for hip fracture or markers of frailty?

Precision and accuracy of measuring changes in bone mineral density by dual-energy X-ray absorptiometry

Higher prevalence of osteoporosis among female Holocaust survivors

Management of cancer treatment-induced bone loss in early breast and prostate cancer - a consensus paper of the Belgian Bone Club

Effects of bisphosphonate treatment on bone repair under immunosuppression using cyclosporine A in adult rats

Biochemical assessment of bone turnover and bone fragility in men